Norgine, CHMP

Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome

Veröffentlicht: 17.03.2026 um 20:14 Uhr, prnewswire.co.uk

Norgine Germany United Kingdom Netherlands France Switzerland Italy Spain Belgium United States of America Austria

en | ES0181380710 | NORGINE | boerse | 68735033 |